Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Why trials sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins stopped, in this sample of ClinicalTrials.gov.

24 stopped trials with a clear reason; 96% ended for non-scientific reasons.

Trials

• A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer
  NCT05574712 · WITHDRAWN · logistics pi
  “Principal Investigator has decided not to activate this trial.”
• Role of Pharyngeal High Resolution Manometry and Impedance in Swallow Function of Head and Neck Cancer Patients
  NCT03372148 · WITHDRAWN · logistics pi
  “Study withdrawn by PI”
• SMART-ER: Symptom Monitoring With Patient-reported Outcomes
  NCT05560685 · TERMINATED · funding business
  “Loss of funding”
• Trial to Promote Recovery From COVID-19 With Endocrine Therapy
  NCT04374279 · WITHDRAWN · logistics pi
  “Limited resources.”
• Camostat With Bicalutamide for COVID-19
  NCT04652765 · TERMINATED · funding business
  “PI Decision to close/stop the study due to no new accrual.”
• Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer
  NCT04331717 · WITHDRAWN · slow accrual
  “accrual on hold”
• Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer
  NCT03800784 · WITHDRAWN · funding business
  “Lack of funding”
• Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients
  NCT04001413 · WITHDRAWN · funding business
  “Sponsor withdrew funding”
• Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
  NCT03707457 · TERMINATED · funding business
  “Funding/material support withdrawn”
• Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer
  NCT03523299 · WITHDRAWN · logistics pi
  “Principal investigator wishes to revisit design and start a new study”
• Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel
  NCT02491411 · TERMINATED · slow accrual
  “The study is terminated due to lower enrollment”
• A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia
  NCT01701375 · TERMINATED · funding business
  “Material sponsor withdrew support”
• Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients
  NCT01493154 · TERMINATED · funding business
  “Study Funding Terminated”
• Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
  NCT01431794 · TERMINATED · manufacturing supply
  “Study was terminated due to cease in manufacturing of study drug.”
• Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma
  NCT01293539 · TERMINATED · other
  “IAC is now recognized as part of standard of care treatment options in the US.”
• Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLC
  NCT00769600 · TERMINATED · slow accrual
  “Low accrual.”
• Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
  NCT00852709 · TERMINATED · slow accrual
  “Lack of accrual”
• Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
  NCT00499733 · TERMINATED · logistics pi
  “The study was terminated per PI decision.”
• Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
  NCT00471653 · TERMINATED · slow accrual
  “low accrual”
• Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies
  NCT00356928 · TERMINATED · slow accrual
  “Poor accrual”
• Study of PET Scans and Serotonin in Hot Flashes Treatment
  NCT00249847 · TERMINATED · slow accrual
  “Unable to complete accrual; elected to close the study in April 2008.”
• Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia
  NCT00245115 · TERMINATED · manufacturing supply
  “Expiration of study supply”
• Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer
  NCT00100828 · TERMINATED · slow accrual
  “Closed due to early stopping rule”
• MRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806
  NCT00433472 · WITHDRAWN · slow accrual
  “not enough interest”

Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.